SRCM
IBB icon

Signature Resources Capital Management’s iShares Biotechnology ETF IBB Stock Holding History

Signature Resources Capital Management’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.09K Buy
+32
New +$5.5K ﹤0.01% 402

Other funds holding IBB

WA
WestEnd Advisors Charlotte, North Carolina $4.49B AUM 19.44% 1-Year Est. Return
AFG
Albion Financial Group Salt Lake City, Utah $1.73B AUM 20.99% 1-Year Est. Return
GIC
Generali Investments CEE Prague, Czech Republic $2.11B AUM 25.53% 1-Year Est. Return
IHL
Investment House LLC Redondo Beach, California $1.92B AUM 25.81% 1-Year Est. Return
AP
Appleton Partners Boston, Massachusetts $1.63B AUM 38.57% 1-Year Est. Return
FMI
Factory Mutual Insurance Waltham, Massachusetts $10.6B AUM 34.1% 1-Year Est. Return
CA
Cumberland Advisors Sarasota, Florida $284M AUM 27.11% 1-Year Est. Return
FNFDCM
Folger Nolan Fleming Douglas Capital Management Washington, District of Columbia $1.22B AUM 34.81% 1-Year Est. Return
AC
Apella Capital West Hartford, Connecticut $7.08B AUM 17.38% 1-Year Est. Return
RFA
Reyes Financial Architecture San Diego, California $179M AUM 31.17% 1-Year Est. Return

Signature Resources Capital Management's IBB Position: Q2 2026 in Review

Signature Resources Capital Management opened a new position in iShares Biotechnology ETF (IBB) in Q2 2026: 32 shares worth $6.09K. The stake represents ﹤0.01% of the portfolio and ranks #402 among its holdings.

285 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Signature Resources Capital Management held 32 shares of iShares Biotechnology ETF worth $6.09K as of Q2 2026.
  • iShares Biotechnology ETF was a new Signature Resources Capital Management position in Q2 2026.
  • iShares Biotechnology ETF made up ﹤0.01% of Signature Resources Capital Management's portfolio in Q2 2026, its #402 holding.
  • 285 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Signature Resources Capital Management's 13F filing for Q2 2026, filed 14 Jul 2026.